Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Chng

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Annals of the Academy of Medicine, Singapore|November 9, 2004
Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring systemL G Lau, W J Chng, T C Liu, et al.
Cell Death and Differentiation|November 24, 2012
T-cell death following immune activation is mediated by mitochondria-localized SARMP Panneerselvam, L P Singh, V Selvarajan, et al.
Oncology Letters|June 29, 2012
Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivoD Chan, J W Tyner, W J Chng, et al.
Leukemia|March 12, 2010
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myelomaW J Chng, M A Gertz, T-H Chung, et al.
Bone Marrow Transplantation|April 30, 2014
Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study GroupE Tse, T S Y Chan, L-P Koh, et al.
Leukemia|April 7, 2011
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myelomaW-J Chng, G F Huang, T H Chung, et al.
Blood Cancer Journal|July 26, 2012
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaS Hart, K C Goh, V Novotny-Diermayr, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Leukemia|January 26, 2017
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCV Selvarajan, M Osato, G S S Nah, et al.
Leukemia|October 7, 2006
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myelomaR Fonseca, S A Van Wier, W J Chng, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Annals of the Academy of Medicine, Singapore|November 9, 2004
Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring systemL G Lau, W J Chng, T C Liu, et al.
Cell Death and Differentiation|November 24, 2012
T-cell death following immune activation is mediated by mitochondria-localized SARMP Panneerselvam, L P Singh, V Selvarajan, et al.
Oncology Letters|June 29, 2012
Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivoD Chan, J W Tyner, W J Chng, et al.
Leukemia|March 12, 2010
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myelomaW J Chng, M A Gertz, T-H Chung, et al.
Bone Marrow Transplantation|April 30, 2014
Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study GroupE Tse, T S Y Chan, L-P Koh, et al.
Leukemia|April 7, 2011
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myelomaW-J Chng, G F Huang, T H Chung, et al.
Blood Cancer Journal|July 26, 2012
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaS Hart, K C Goh, V Novotny-Diermayr, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Leukemia|January 26, 2017
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCV Selvarajan, M Osato, G S S Nah, et al.
Leukemia|October 7, 2006
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myelomaR Fonseca, S A Van Wier, W J Chng, et al.
Pageof 4